News
The possible mechanism for false positives, in both cases, is not the chemical similarity of Zantac to amphetamines, but through the presence of unintended reactions between Zantac and the ...
Illinois resident Angela Valadez had alleged that her cancer was a result of taking over-the-counter Zantac and generic versions of it from 1995 to 2014.
Zantac and its generic varieties are coming off store shelves after the Food and Drug Administration revealed it found a chemical that could be linked to cancer. Monday, pharmacy chains CVS and ...
Ranitidine was first developed in 1981 in Europe by Glaxo Holdings Ltd, now part of GlaxoSmithKline (GSK) PLC. It got its first American approval in 1983, along with 31 other countries.
There are other H2-receptor blockers that work by the same mechanism as ranitidine. These include nizatidine (sold via the brand name Axid), famotidine (Pepcid, Pepcid AC), and cimetidine (Tagamet ...
The science that led to Zantac’s withdrawal is very different from the basis of the recently dismissed Zantac litigation (“The Zantac Scare and Junk Science,” Review & Outlook, Dec. 9). The ...
A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...
Hosted on MSN6mon
Govt says no plan to ban heartburn drug ranitidine, carcinogenic impurities within safe limitsIn 2019, evidence showed that an impurity in drug degrades over time to form probable carcinogenic compound. Ranitidine is sold as heartburn medicine under names Rantac, Aciloc & Zinetac.
I will only conclude that it is possible for NDMA formation from ranitidine to also result from reaction in the gastrointestinal tract following oral administration of ranitidine formulations…. I have ...
The press typically treats lawsuits against business as inherently righteous and amplifies the junk science behind them. So in case you missed it, a federal judge on Tuesday dismissed claims that ...
It will offer the first test of how Zantac cancer claims may fare in state courts, and its outcome could depend heavily on what expert testimony Grillo allows. Sign up here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results